Biotechnology Jobs

GSK · Durham, United States · US$188,100 – US$313,500 pa

Leads end-to-end application of Model-Informed Drug Development and clinical pharmacology strategy across the drug development lifecycle, from first-in-human studies through filing and lifecycle management. Partners with digital medicine, translational imaging, modelling and biostatistics teams, and drafts regulatory content for FDA, EMA, CDE, PMDA and ICH submissions. Based in the newly formed Clinical Pharmacology and Quantitative Medicine organisation, with a strong publication and scientific leadership remit.

GSK · Stevenage

Leads the development and execution of the analytical (QC testing) network strategy across GSK's global supply chain, translating approved strategy into an operational roadmap and securing endorsement from governance forums such as the Supply Chain Review Board. Drives benchmarking, KPI and reporting frameworks, and capability building across GSC Strategy, with focus on large molecules, ADCs and Oligos.

GSK · London · US$222,750 – US$371,250 pa

Serves as the physician within a clinical programme team, leading medical monitoring and safety oversight for oncology studies and interpreting clinical and safety data. Partners with the Senior Scientist and cross-functional teams on protocol development, regulatory interactions and investigator engagement, with a focus on GI oncology. Requires an on-site office presence two to three days a week.

GSK · Waltham, United States · US$222,750 – US$371,250 pa

Serves as the physician on a clinical programme team, leading medical monitoring and safety oversight for GI oncology studies. Interprets clinical and safety data, contributes to protocol development, and engages investigators and regulators. Works within a Clinical Matrix Team alongside Clinical Operations, Biostatistics, Regulatory and Pharmacovigilance, with on-site presence 2-3 days a week.

GSK · Stevenage · US$222,750 – US$371,250 pa

Serves as the physician within an oncology clinical programme team, leading medical monitoring, safety oversight and clinical data interpretation for GI studies. Partners with a Senior Scientist and cross-functional matrix teams on protocol development, regulatory interactions and investigator engagement. Requires on-site presence 2-3 days a week, with the Stevenage base relocating to Cambridge, UK by early 2029.

GSK · London · US$284,250 – US$473,750 pa

Senior physician leader providing medical oversight, safety evaluation and clinical data interpretation across sarcoma oncology studies, from protocol design through regulatory interactions. Serves on the Clinical Matrix Team, mentors Medical Directors and engages external experts, with a minimum two days a week on-site presence.

GSK · Waltham, United States · US$284,250 – US$473,750 pa

Senior physician leader providing medical oversight, safety evaluation and clinical data interpretation across sarcoma oncology studies, from protocol design through regulatory interactions. Sits on the Clinical Matrix Team, mentors Medical Directors and engages external experts, KEEs and advisory boards. Requires deep soft tissue sarcoma and osteosarcoma drug development expertise.

GSK · Stevenage · US$284,250 – US$473,750 pa

Senior physician leader providing medical oversight, safety monitoring and clinical data interpretation across sarcoma oncology studies, from protocol design through regulatory interactions. Serves as a senior member of the Clinical Matrix Team, mentoring Medical Directors and engaging external experts, with a minimum two days a week on-site presence.

GSK · Zug, Switzerland · US$284,250 – US$473,750 pa

Senior physician leader providing medical oversight, safety evaluation and clinical data interpretation across sarcoma oncology studies, from protocol design through regulatory interaction. Serves as a senior member of the Clinical Matrix Team, mentoring Medical Directors and engaging external experts, with a minimum two-day on-site office presence.

GSK · Stevenage · US$242,250 – US$403,750 pa

Accountable for end-to-end clinical development of a multi-tumor oncology asset, from first-in-human through registrational trials, regulatory approval and initial market launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams spanning research, precision medicine, medical affairs and commercial. Requires deep antibody-drug conjugate and global health authority experience.

GSK · Waltham, United States · US$242,250 – US$403,750 pa

Accountable for end-to-end clinical development strategy for a multi-tumor oncology asset, spanning first-in-human through registrational trials, regulatory approval and initial launch. Acts as senior clinical representative at governance forums and leads cross-functional collaboration across research, precision medicine, medical affairs and commercial in a global matrix.

GSK · Zug, Switzerland · US$242,250 – US$403,750 pa

Accountable for end-to-end clinical development of a multi-tumor oncology asset, from first-in-human through registrational trials, regulatory approval and launch. Leads cross-functional strategy with research, precision medicine, medical affairs and commercial partners, and represents the program at senior governance forums. Requires deep antibody-drug conjugate and global regulatory experience.

GSK · London · US$242,250 – US$403,750 pa

Accountable for end-to-end clinical development strategy for a multi-tumor oncology asset, spanning first-in-human through registrational trials, regulatory filing and initial market launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams across research, precision medicine, medical affairs and commercial. Requires deep antibody-drug conjugate and global health authority experience.

GSK · Waltham, United States

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and launch. Sets disease-area strategy, chairs governance forums and scientific advisory boards, and line-manages clinical development leads and medical directors within a global matrix team.

GSK · Stevenage

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and launch. Provides portfolio oversight, chairs governance forums and scientific advisory boards, and line-manages Clinical Development Leads and Medical Directors within a global matrix team.